Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1125 of 2051 entries
View as:

A Study of MK2206 in Locally Advanced or Metastatic Solid Tumors (2206-007)

Phase: N/A Priority: Normal
NCT ID: NCT01071018 Org: User:
Start: 02/28/10 End: 09/30/11 Due: 09/30/12

Trial to Determine the Maximum Tolerated Dose (MTD) Based on Safety and Tolerability, of Org 26576 in Participants With Major Depressive Disorder (174001/P05704/MK-8777-001)

Phase: N/A Priority: Normal
NCT ID: NCT00610649 Org: User:
Start: 09/20/07 End: 12/10/08 Due: 12/10/09

Study of Pomalidomide and Low Dose Dexamethasone With or Without Pembrolizumab (MK-3475) in Refractory or Relapsed and Refractory Multiple Myeloma (rrMM) (MK-3475-183/KEYNOTE-183)

Phase: N/A Priority: Normal
NCT ID: NCT02576977 Org: User:
Start: 10/19/15 End: 07/16/20 Due: 07/16/21

Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)

Phase: N/A Priority: Normal
NCT ID: NCT00686725 Org: User:
Start: 06/24/08 End: 09/28/11 Due: 09/28/12

MK0767 Added to Insulin Therapy in Patients With Type 2 Diabetes (0767-030)

Phase: N/A Priority: Normal
NCT ID: NCT00543816 Org: User:
Start: 08/31/03 End: 11/30/03 Due: 11/30/04

Single-Dose Study of MK-4250 Monotherapy in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-4250-002)

Phase: N/A Priority: Normal
NCT ID: NCT03351699 Org: User:
Start: 01/18/18 End: 11/02/18 Due: 11/02/19

Evaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123)

Phase: N/A Priority: Normal
NCT ID: NCT00828269 Org: User:
Start: 04/30/09 End: 03/31/10 Due: 03/31/11

A Study of the Effects of Single Dose Corticosteroids on Response to Allergens

Phase: N/A Priority: Normal
NCT ID: NCT00828061 Org: User:
Start: 02/04/09 End: 05/21/09 Due: 05/21/10

Biomarkers of Prednisolone Treatment (P05888)

Phase: N/A Priority: Normal
NCT ID: NCT00971724 Org: User:
Start: 05/31/06 End: 03/31/08 Due: 03/31/09

Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037)

Phase: N/A Priority: Normal
NCT ID: NCT01227265 Org: User:
Start: 11/19/10 End: 04/16/13 Due: 04/16/14

The Growth Factor Signature (GFS) as an Intermediate Biomarker of Response for Development of PI3K-Pathway Inhibitors in Patients With Breast Cancer (MK-8669-050)

Phase: N/A Priority: Normal
NCT ID: NCT01220570 Org: User:
Start: 09/30/10 End: 12/31/12 Due: 12/31/13

Study Assessing Single and Multiple Doses of IDX21459 in Healthy and HCV-Infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02112942 Org: User:
Start: 03/31/14 End: 06/30/14 Due: 06/30/15

Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C (Study P02538 Part 1)

Phase: N/A Priority: Normal
NCT ID: NCT00104052 Org: User:
Start: 02/28/05 End: 11/30/07 Due: 11/30/08

Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Are Non-responders to Previous Treatment (MK-7009-045)

Phase: N/A Priority: Normal
NCT ID: NCT01405560 Org: User:
Start: 09/02/11 End: 03/29/13 Due: 03/29/14

Effects of Andriol Testocaps in Symptomatic Late-Onset Hypogonadism (43203)

Phase: N/A Priority: Normal
NCT ID: NCT00434824 Org: User:
Start: 11/30/01 End: 07/31/04 Due: 07/31/05

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

Phase: N/A Priority: Normal
NCT ID: NCT06637423 Org: User:
Start: 12/20/24 End: 07/31/28 Due: 07/31/29

Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)

Phase: N/A Priority: Normal
NCT ID: NCT01296412 Org: User:
Start: 03/11/11 End: 02/29/12 Due: 02/28/13

Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175)

Phase: N/A Priority: Normal
NCT ID: NCT00537017 Org: User:
Start: 11/23/07 End: 11/19/09 Due: 11/19/10

A Study of Islatravir (MK-8591) in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus-1 Infected Participants (MK-8591-003)

Phase: N/A Priority: Normal
NCT ID: NCT02217904 Org: User:
Start: 09/17/15 End: 05/11/17 Due: 05/11/18

Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1))

Phase: N/A Priority: Normal
NCT ID: NCT00111813 Org: User:
Start: 09/30/05 End: 05/31/11 Due: 05/31/12

Effects of Switching From ATRIPLA™ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028)

Phase: N/A Priority: Normal
NCT ID: NCT02652260 Org: User:
Start: 03/04/16 End: 02/07/24 Due: 02/07/25

A Phase II Study of MK0457 in Patients With T315I Mutant CML and Ph+All (0457-008)

Phase: N/A Priority: Normal
NCT ID: NCT00405054 Org: User:
Start: 12/31/06 End: 06/30/09 Due: 06/30/10

A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00092300 Org: User:
Start: 05/31/02 End: - Due: -

Activity of MK-8504 in Anti-retroviral-naïve, Human Immunodeficiency Virus 1 (HIV-1) Infected Participants (MK-8504-002)

Phase: N/A Priority: Normal
NCT ID: NCT03188523 Org: User:
Start: 09/08/17 End: 06/04/18 Due: 06/04/19

Post Marketing Observational Study of Retreatment of Chronic Hepatitis C With Peginterferon Alpha and Ribavirin (Study P06011)

Phase: N/A Priority: Normal
NCT ID: NCT01098097 Org: User:
Start: 06/30/09 End: 10/31/11 Due: 10/31/12